Table III.
Source | Year | Country | Study population | Methods | Prevalence | Recovery time | Topic | STROBE score* | |
---|---|---|---|---|---|---|---|---|---|
1 | Altundag A 71 | 2020 | Turkey, USA | 91 cases: 24 cases COVID-19 patients, 38 patients with PIOD, and a control group of 29 patients | CT scan, MRI | COVID-19 patients: 100% anosmic | N/A | Radiological study | 22 |
2 | Kandemirli SG 72 | 2021 | Turkey, USA | 23 COVID-19 patients | Sniffin’ sticks, CT scan, MRI | COVID-19 patients: 100% anosmic | N/A | Radiological study | 20 |
3 | Lechien JR 73 | 2020 | Multicentric | 16 COVID-19 patients | Validated questionnaire, Sniffin’ sticks, olfactory cleft examination, CT scan | COVID-19 patients: 100% anosmic | N/A | Radiological study | 22 |
4 | Tekcan Sanli DE 74 | 2021 | Turkey, USA | 50 COVID-19 patients | Sniffin’ sticks, CT scan. | N/A | N/A | Radiological study | 21 |
5 | Yildirim D 75 | 2021 | Turkey, USA | 31 COVID-19 patients, 97 patients with PIOD | Olfactory bulb MRI, DTI, and olfactory fMRI | COVID-19 patients: 100% anosmic; PIOD patients: 18.6% hyposmic, 81.4% anosmic | N/A | Radiological study | 21 |
PIOD: indicates post-infectious olfactory disorder; CT: computed tomography; MRI: magnetic resonance imaging; N/A: not applicable.
*Scores interval from 0 to 22, with higher scores showing better study quality 12.